Frontiers in Cell and Developmental Biology,
Journal Year:
2024,
Volume and Issue:
12
Published: Dec. 5, 2024
Tumor,
as
the
second
leading
cause
of
death
globally,
following
closely
behind
cardiovascular
diseases,
remains
a
significant
health
challenge
worldwide.
Despite
existence
various
cancer
treatment
methods,
their
efficacy
is
still
suboptimal,
necessitating
development
safer
and
more
efficient
strategies.
Additionally,
advancement
personalized
therapy
offers
further
possibilities
in
treatment.
Nanomedicine,
promising
interdisciplinary
field,
has
shown
tremendous
potential
prospects
diagnosis
cancer.
As
an
emerging
approach
oncology,
application
nanomedicine
primarily
focuses
on
targeted
drug
delivery
systems
such
passive
targeting
delivery,
active
environmentally
responsive
well
imaging
diagnostics
tumor
biomarker
detection,
cell
vivo
imaging.
However,
it
faces
challenges
regarding
safety,
biocompatibility,
other
issues.
This
review
aims
to
explore
advances
use
nanomaterials
field
investigate
developing
therapies
care,
providing
direction
for
clinical
translation
application.
Exploration,
Journal Year:
2024,
Volume and Issue:
unknown
Published: June 26, 2024
Abstract
The
immunosuppressive
microenvironment
of
glioblastoma
multiforme
(GBM)
severely
impacts
the
response
to
various
treatments,
including
systemic
chemotherapy.
Targeted
reprogramming
GBM
using
RNA
interference
(RNAi)
is
largely
restricted
by
poor
brain
delivery
efficiency
and
targeting
specificity.
Herein,
an
acid‐cleavable
transferrin
(Tf)
decorated
engineering
exosome‐based
brain‐targeting
system
(ACTE)
was
proposed
efficiently
deliver
small
towards
transform
growth
factor‐β
(siTGF‐β)
doxorubicin
(DOX)
site
for
combination
chemo‐immunotherapy.
siTGF‐β
DOX
co‐loaded
ACTE,
termed
as
DOX&siTGF‐β@ACTE
(Ds@ACTE),
designed
specifically
recognize
Tf
receptor
(TfR)
on
blood‐brain
barrier
(BBB).
Subsequently,
Ds@ACTE
undergoes
acid‐responsive
detachment
within
lysosome
capillary
endothelial
cells,
leading
separation
DOX&siTGF‐β@Exo
(Ds@Exo)
from
Tf‐TfR
complex
enhanced
BBB
transcytosis.
After
crossing
BBB,
separated
Ds@Exo
can
further
target
cells
via
homing
effect.
In
vivo
studies
validated
that
significantly
downregulated
TGF‐β
expression
reprogram
microenvironment,
thereby
reinforce
chemotherapeutic
effect
DOX‐induced
anti‐tumor
immune
response.
effectiveness
this
strategy
not
only
provide
thinking
designing
a
more
intelligent
based
engineered
exosomes
but
also
explore
effective
treatment
regimen
GBM.
Advanced Materials,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 16, 2025
The
radiotherapy-induced
release
of
DNA
fragments
can
stimulate
the
cyclic
guanosine
monophosphate-adenosine
monophosphate
synthase-stimulator
interferon
genes
(cGAS-STING)
pathway
to
prime
antitumor
immunity,
but
this
is
expected
be
less
potent
because
inefficient
cytosolic
delivery
negatively
charged
fragments.
In
study,
manganese-coordinated
chitosan
(CS-Mn)
microparticles
with
selective
DNA-capturing
capacity
are
concisely
prepared
via
a
coordination-directed
one-pot
synthesis
process
potentiate
immunogenicity
radiotherapy.
obtained
CS-Mn
that
undergo
rapid
disassembly
under
physiological
conditions
selectively
bind
form
positively
DNA-CS
assemblies
strong
electrostatic
interaction
between
linear
and
molecules.
They
thus
enable
efficient
in
presence
serum
cooperate
Mn2+
activate
cGAS-STING
dendritic
cells.
Upon
intratumoral
injection,
markedly
enhance
efficacy
radiotherapy
against
both
irradiated
distal
tumors
different
tumor
models
collectively
promoting
tumor-infiltrating
CD8+
T-cell
stemness
activation
innate
immunity.
radiosensitization
effect
further
augmented
by
concurrently
applying
anti-programmed
cell
death
protein
1
(anti-PD-1)
immunotherapy.
This
work
highlights
an
ingenious
strategy
prepare
Trojan
horse-like
as
cGAS-STING-activating
radiosensitizers
for
effective
radioimmunotherapy.
Biomaterials Research,
Journal Year:
2024,
Volume and Issue:
28
Published: Jan. 1, 2024
The
reprogramming
of
tumor
metabolism
presents
a
substantial
challenge
for
effective
immunotherapy,
playing
crucial
role
in
developing
an
immunosuppressive
microenvironment.
In
particular,
the
degradation
amino
acid
L-tryptophan
(Trp)
to
kynurenine
(Kyn)
by
indoleamine-pyrrole
2,3-dioxygenase
1
(IDO1)
is
one
most
clinically
validated
pathways
immune
suppression.
Thus,
regulating
Trp/Kyn
IDO1
inhibition
represents
promising
strategy
enhancing
immunotherapy.
Herein,
metabolism-regulated
nanoparticles
are
prepared
through
metal
coordination-driven
assembly
inhibitor
(NLG919)
and
stimulator
interferon
genes
(STING)
agonist
(MSA-2)
enhanced
After
intravenous
administration,
assembled
could
efficiently
accumulate
tumors,
bioavailability
NLG919
down-regulating
Trp
Kyn
remodel
Meanwhile,
released
MSA-2
evoked
potent
STING
pathway
activation
triggering
response.
antitumor
immunity
induced
significantly
inhibited
development
primary
metastatic
as
well
B16
melanoma.
Overall,
this
study
provided
novel
paradigm
immunotherapy
synergistic
activation.
Advanced Science,
Journal Year:
2024,
Volume and Issue:
11(39)
Published: Aug. 19, 2024
Abstract
Pyroptosis
possesses
potent
antitumor
immune
activity,
making
pyroptosis
inducer
development
a
promising
direction
for
tumor
immunotherapy.
Persistent
luminescence
nanoparticles
(PLNPs)
are
highly
sensitive
optical
probes
extensively
employed
in
diagnosis
and
therapy.
However,
based
on
PLNPs
has
not
been
reported
yet.
Herein,
polyethylene
glycol–poly
lactic
acid‐co‐glycolic
acid
(PEG–PLGA:
PP)
modified
biodegradable
CaS:Eu
2+
(CSE@PP)
synthesized
as
immunotherapy
the
first
time.
The
CSE@PP
biowindow
persistent
(PersL)
pH‐responsive
degradation
properties,
allowing
it
to
remain
stable
under
neutral
pH
but
degrade
when
exposed
weak
(pH
<
6.5).
During
within
tumor,
constantly
releases
H
2
S
Ca
while
its
PersL
gradually
fades
away.
Thus,
signal
can
self‐monitor
release.
Furthermore,
released
result
mitochondrial
dysfunction
inactivation
of
reactive
oxygen
species
scavenging
enzymes,
synergistic
facilitating
intracellular
oxidative
stress,
which
induces
caspase‐1/GSDM‐D
dependent
subsequent
responses.
In
word,
is
confirmed
that
release
pyroptosis‐mediated
Immunotherapy.
This
work
will
facilitate
biomedical
applications
inspire
pyroptosis‐induced
Advanced Healthcare Materials,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 2, 2025
Coacervates
have
garnered
significant
attention
as
potential
drug
carriers.
However,
the
instability
resulting
from
their
intrinsic
membrane-free
nature
restricts
application
of
coacervates
in
delivery.
Herein,
engineering
poly(ethylene
glycol)
nanoparticles
(PEG
NPs)
is
reported
using
composed
PEG
and
polyphenols
templates,
where
subsequently
cross-linked
based
on
different
chemistries
(e.g.,
thiol-disulfide
exchange,
click
chemistry,
Schiff
base
reaction).
The
assembly
strategy
avoids
template
removal
process
resultant
NPs
exhibit
excellent
stability
physiological
environment
compared
to
coacervates.
presence
enables
loading
various
cargos
including
metal
ions
(i.e.,
Ru,
Gd,
Mn,
Fe)
molecules
doxorubicin),
which
demonstrates
promise
magnetic
resonance
imaging
combinational
tumor
therapy.
This
work
provides
a
promising
promote
development
coacervate-derived
delivery
system
for
biomedical
applications.
To
simplify
the
composition
and
improve
efficacy
of
metal-phenolic
network
(MPN)-based
nanomedicine,
herein,
we
designed
an
MPN
platform
to
deliver
programmed
death
ligand-1
(PD-L1)
antibody
(anti-PD-L1)
for
combined
tumor
chemo/chemodynamic/immune
therapy.
Here,
generation
5
poly(amidoamine)
dendrimers
conjugated
with
gossypol
(Gos)
through
boronic
ester
bonds
were
used
as
a
synthetic
polyphenol
coordinate
Mn2+,
then
complexed
anti-PD-L1
obtain
nanocomplexes
(for
short,
DPGMA).
The
prepared
DPGMA
exhibited
good
water
dispersibility
hydrodynamic
size
166.3
nm
tumor-microenvironment-responsive
drug
release
behavior.
integration
Gos
Mn2+
within
resulted
in
significant
inhibition
immunogenic
cell
activation
Gos-mediated
chemotherapy
Mn2+-catalyzed
chemodynamic
therapy,
respectively,
thereby
leading
dendritic
maturation
due
role
played
mediate
stimulator
interferon
genes
(STING)
pathway.
Moreover,
promoted
recognition
uptake
by
PD-L1-overexpressed
tumors
targeting,
achieving
combinational
therapy
mouse
melanoma
model,
where
immunotherapy
modes
three
parts
via
chemotherapy/CDT-mediated
ICD,
Mn2+-mediated
STING
activation,
antibody-mediated
immune
checkpoint
blockade.
With
Mn2+-endowed
r1
relaxivity
(1.38
mM–1
s–1),
can
also
be
MR
imaging.
dendrimer-mediated
may
developed
advanced
nanomedicine
tackle
other
cancer
types.
Frontiers in Pharmacology,
Journal Year:
2025,
Volume and Issue:
16
Published: Feb. 19, 2025
The
underlying
cause
of
psoriasis,
a
chronic
inflammatory
skin
condition
driven
by
an
immune
response,
remains
topic
active
investigation
and
is
not
yet
fully
elucidated.
Recent
studies
have
revealed
that
ergothioneine,
small
molecule
sulfur-containing
histidine
derivative
can
be
ingested
from
the
daily
diet
accumulated
in
body,
exhibits
antioxidant
capacity
comparable
to
glutathione.
Nevertheless,
there
paucity
empirical
data
concerning
precise
impact
ergothioneine
context
anti-inflammatory
processes,
particularly
psoriasis.
In
light
aforementioned
considerations,
present
study
was
undertaken
with
objective
conducting
comprehensive
evaluation
potential
(EGT)
investigate
its
on
pathogenesis
efficacy
EGT
reducing
extent
dorsal
lesions
psoriasis
model
mice
confirmed
through
vivo
experimental
observation.
Furthermore,
inhibitory
effect
responses
at
cellular
level
investigated,
specifically
LPS-induced
mouse
macrophage
(RAW264.7)
human
keratinocyte-forming
cell
(HaCaT)
models.
results
demonstrated
introduction
different
concentrations
into
resulted
notable
effects,
as
evidenced
reduction
dose
dependent
decline
key
cytokines,
including
interleukin-1β
(IL-1β),
cyclooxygenase-2
(COX-2)
tumour
necrosis
factor-α
(TNF-α).
observed
reverse
LPS
induced
increase
ratio
M1
M2
macrophages.
also
markedly
suppress
phosphorylation
JAK/STAT3
NF-κB,
offering
novel
insight
mechanism
EGT.
conclusion,
findings
consistently
had
significant
ameliorative
imiquimod-induced
modulating
NF-κB/JAK-STAT3
signalling
pathway.
This
provides
strong
rationale
for
application
treatment.
Advanced Functional Materials,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 12, 2025
Abstract
With
the
growing
demand
for
sustainable
energy
and
environmental
solutions,
osmotic
harvesting
has
become
a
promising
technology,
but
challenges
in
membrane
stability
multifunctionality
remain.
This
study
introduces
novel
graphene
oxide
composite
(GO‐Au@UiO‐66‐NH
2
‐PSSA,
GAUP)
that
achieves
excellent
conversion
multifunctionality.
The
hierarchical
pore
structure
UiO‐66‐NH
ensures
optimized
ion
transport
paths
selective
sieving.
When
GAUP
is
photoexcited,
localized
surface
plasmon
resonance
(LSPR)
effect
of
gold
nanoparticles
(Au
NPs)
generates
abundant
hot
electrons,
which
migrate
from
heterojunction
interface
are
captured
by
UiO‐66‐NH₂
to
produce
photogenerated
holes,
reducing
electron‐hole
recombination
enhancing
photocurrent,
thus
achieving
high‐performance
(16.5
W
m
−2
).
It
dye
degradation
rate
over
90%
wastewater
bactericidal
99%
against
Gram‐negative
bacteria,
reflecting
its
strong
remediation
capability.
effectively
addresses
ongoing
systems
treatment,
representing
transformative
advancement
nanofluidic
technology.
Future
research
may
focus
on
improving
broader
practical
applications,
promoting
deeper
integration
renewable
solutions
with
management.